http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104000938-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
filingDate 2014-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104000938-B
titleOfInvention Traditional Chinese medicine composition for treating IgA nephropathy and application thereof
abstract The invention relates to a traditional Chinese medicine composition for treating IgA nephropathy and an application thereof. The traditional Chinese medicine composition is prepared from the following medicinal raw materials in parts by weight: 6-12 parts of radix bupleuri, 9-15 parts of scutellaria baicalensis, 6-9 parts of codonopsis pilosula, 9-15 parts of astragalus membranaceus, 15-30 parts of sculellaria barbata, 15-30 parts of oldenlandia diffusa and 15-30 parts of solanum lyratum. The traditional Chinese medicine composition has the advantages that the compatibility of the medicines is precise and appropriate, the sculellaria barbata, the oldenlandia diffusa and the solanum lyratum are monarch medicines and are capable of clearing away heat and toxic materials, dissipating stasis and dispelling dampness, the radix bupleuri is an adjuvant and can eliminate the evils located at Shaoyang yang channel, the scutellaria baicalensis can clear away the heat located at Shaoyang channel, the codonopsis pilosula and the scutellaria baicalensis are capable of benefiting qi and strengthening the body resistance so as to eliminate pathogens, and the traditional Chinese medicine composition can be used for effectively reducing the 24 hour urine protein quantitation of patients with the IgA nephropathy and improving hematuresis conditions, is low in medicine cost and has no toxic or side effects.
priorityDate 2014-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101224279-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30426
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC9X4J0
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID649199
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID86864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55891
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DQU4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49800050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP85165
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86643
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID254027
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID65409
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30424
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID13037
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID340439
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID65409
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID230192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22227373
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID230192
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID13037
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID254027
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31351
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID340439
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID86864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451822344
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452888886
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07845
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID649199

Total number of triples: 43.